Skip to main content
. 2010 Jan;159(1):45–56. doi: 10.1111/j.1365-2249.2009.04006.x

Table 1.

Clinical and laboratory data at time of inclusion in the study.

Patient Age (years) HLA HIV status Time elapsed from classic VIN clinical onset Previous treatments Previous cervical HPV disease Size of vulvar lesions
1 23 A2/33,B7/55 Negative 6 months None None known 10 cm2
DR1501/1601
2 28 A2/32, B7/44 Negative 37 months Cryotherapy High grade CIN 1 cm2
DR1501/0801
3 67 A2/29, B44 Negative 13 months Surgery None known 0
DR1501/0701
4 64 A25/66, B7/55 Negative 8 months Surgery None known 0
DR1501/1501
5 41 A1/2, B7/44 Negative 160 months Efudix, interferon High grade CIN 0·5 cm2
DR1501/0404 or 0423
6 34 A3/28, B7/8 Negative 54 months Electrocoagulation High grade CIN 0
DR1501/0311
7 37 A28/29, B44/51 Negative 7 months None None known 2 cm2
DR1301/1101
8 53 A2/23, B35/62 Negative 11 months Electrocoagulation None known 0
DR0701/0701
9 34 A2/9, B13/15 Negative 6 months None None known 0·5 cm2
DR0701/0701
10 39 A2/9, B17/40 Negative 19 months Laser vaporization None known 4·09 cm2
DR0701/0411
11 50 A2/29, B7/37 Negative 18 months None High grade CIN 4·5 cm2
DR0701/1101
12 27 A1/2, B8 Negative 4 months None Low grade CIN 3 cm2
DR1501/0301
13 34 A1/2, B13/51 Negative 168 months Laser vaporization High grade CIN 20 cm2
DR0701/1101 Interferon, 5-FU
14 42 A3/29, B7/38 Negative 6 months Laser vaporization None known 2 cm2
DR1001/1101
15 38 A9/35, B44 Positive 18 months Imiquimod Low grade CIN 1 cm2
DR0301/1101
16 49 A11/19, B13/22 Negative 54 months Laser vaporization None known 0·5 cm2
DR0301/0701 Surgery

HLA, human leucocyte antigen; HIV, human immunodeficiency virus; HPV, human papillomavirus; VIN, vulvar intra-epithelial neoplasia.